139 related articles for article (PubMed ID: 25247335)
1. The effect of IGF2BP2 gene polymorphisms on pioglitazone response in Chinese type 2 diabetes patients.
Zhang LF; Pei Q; Yang GP; Zhao YC; Mu YF; Huang Q; Zhu YL
Pharmacology; 2014; 94(3-4):115-22. PubMed ID: 25247335
[TBL] [Abstract][Full Text] [Related]
2. IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population.
Huang Q; Yin JY; Dai XP; Pei Q; Dong M; Zhou ZG; Huang X; Yu M; Zhou HH; Liu ZQ
Acta Pharmacol Sin; 2010 Jun; 31(6):709-17. PubMed ID: 20523342
[TBL] [Abstract][Full Text] [Related]
3. Replication of association study between type 2 diabetes mellitus and IGF2BP2 in Han Chinese population.
Zhang SM; Xiao JZ; Ren Q; Han XY; Tang Y; Yang WY; Ji LN
Chin Med J (Engl); 2013 Nov; 126(21):4013-8. PubMed ID: 24229666
[TBL] [Abstract][Full Text] [Related]
4. Impact of retinol binding protein 4 polymorphism on rosiglitazone response in Chinese type 2 diabetic patients.
Zhou F; Huang Q; Dai X; Yin J; Wu J; Zhou H; Gong Z; Liu Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 36(10):949-57. PubMed ID: 22086013
[TBL] [Abstract][Full Text] [Related]
5. Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes.
Liu HL; Lin YG; Wu J; Sun H; Gong ZC; Hu PC; Yin JY; Zhang W; Wang D; Zhou HH; Liu ZQ
Eur J Clin Pharmacol; 2008 Jul; 64(7):663-71. PubMed ID: 18438653
[TBL] [Abstract][Full Text] [Related]
6. Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
Derosa G; Cicero AF; D'Angelo A; Gaddi A; Ciccarelli L; Piccinni MN; Salvadeo SA; Pricolo F; Ferrari I; Gravina A; Ragonesi PD
Clin Ther; 2006 May; 28(5):679-88. PubMed ID: 16861090
[TBL] [Abstract][Full Text] [Related]
7. PPAR-γ2 and PTPRD gene polymorphisms influence type 2 diabetes patients' response to pioglitazone in China.
Pei Q; Huang Q; Yang GP; Zhao YC; Yin JY; Song M; Zheng Y; Mo ZH; Zhou HH; Liu ZQ
Acta Pharmacol Sin; 2013 Feb; 34(2):255-61. PubMed ID: 23147557
[TBL] [Abstract][Full Text] [Related]
8. NAMPT -3186C/T polymorphism affects repaglinide response in Chinese patients with Type 2 diabetes mellitus.
Sheng FF; Dai XP; Qu J; Lei GH; Lu HB; Wu J; Xu XJ; Pei Q; Dong M; Liu YZ; Zhou HH; Liu ZQ
Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):550-4. PubMed ID: 21631570
[TBL] [Abstract][Full Text] [Related]
9. Common polymorphisms of the peroxisome proliferator-activated receptor-gamma (Pro12Ala) and peroxisome proliferator-activated receptor-gamma coactivator-1 (Gly482Ser) and the response to pioglitazone in Chinese patients with type 2 diabetes mellitus.
Hsieh MC; Lin KD; Tien KJ; Tu ST; Hsiao JY; Chang SJ; Lin SR; Shing SJ; Chen HC
Metabolism; 2010 Aug; 59(8):1139-44. PubMed ID: 20045142
[TBL] [Abstract][Full Text] [Related]
10. Serine racemase rs391300 G/A polymorphism influences the therapeutic efficacy of metformin in Chinese patients with diabetes mellitus type 2.
Dong M; Gong ZC; Dai XP; Lei GH; Lu HB; Fan L; Qu J; Zhou HH; Liu ZQ
Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):824-9. PubMed ID: 21933224
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study.
Chappuis B; Braun M; Stettler C; Allemann S; Diem P; Lumb PJ; Wierzbicki AS; James R; Christ ER
Diabetes Metab Res Rev; 2007 Jul; 23(5):392-9. PubMed ID: 17211855
[TBL] [Abstract][Full Text] [Related]
12. The association of adiponectin allele 45T/G and -11377C/G polymorphisms with Type 2 diabetes and rosiglitazone response in Chinese patients.
Sun H; Gong ZC; Yin JY; Liu HL; Liu YZ; Guo ZW; Zhou HH; Wu J; Liu ZQ
Br J Clin Pharmacol; 2008 Jun; 65(6):917-26. PubMed ID: 18429970
[TBL] [Abstract][Full Text] [Related]
13. Effects of NOS1AP rs12742393 polymorphism on repaglinide response in Chinese patients with type 2 diabetes mellitus.
Wang T; Wang Y; Lv DM; Song JF; Lu Q; Gao X; Zhang F; Guo H; Li W; Yin XX
Pharmacotherapy; 2014 Feb; 34(2):131-9. PubMed ID: 24338736
[TBL] [Abstract][Full Text] [Related]
14. Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients.
Huang Q; Yin JY; Dai XP; Wu J; Chen X; Deng CS; Yu M; Gong ZC; Zhou HH; Liu ZQ
Eur J Clin Pharmacol; 2010 Dec; 66(12):1207-15. PubMed ID: 20809084
[TBL] [Abstract][Full Text] [Related]
15. Effects of UCP2 -866 G/A and ADRB3 Trp64Arg on rosiglitazone response in Chinese patients with Type 2 diabetes.
Yang M; Huang Q; Wu J; Yin JY; Sun H; Liu HL; Zhou HH; Liu ZQ
Br J Clin Pharmacol; 2009 Jul; 68(1):14-22. PubMed ID: 19659999
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Fogari E; Bertone G; Ciccarelli L; Piccinni MN
Clin Ther; 2004 May; 26(5):744-54. PubMed ID: 15220018
[TBL] [Abstract][Full Text] [Related]
17. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.
Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE;
Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes.
Berneis K; Rizzo M; Stettler C; Chappuis B; Braun M; Diem P; Christ ER
Expert Opin Pharmacother; 2008 Feb; 9(3):343-9. PubMed ID: 18220486
[TBL] [Abstract][Full Text] [Related]
19. The associations of IGF2, IGF2R and IGF2BP2 gene polymorphisms with gestational diabetes mellitus: A case-control study.
Li W; She L; Zhang M; Yang M; Zheng W; He H; Wang P; Dai Q; Gong Z
PLoS One; 2024; 19(5):e0298063. PubMed ID: 38701040
[TBL] [Abstract][Full Text] [Related]
20. Effects of pioglitazone vs glibenclamide on postprandial increases in glucose and triglyceride levels and on oxidative stress in Japanese patients with type 2 diabetes.
Mori Y; Itoh Y; Obata T; Tajima N
Endocrine; 2006 Feb; 29(1):143-8. PubMed ID: 16622303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
